Targeting of oncogenic Kras to the pancreatic Nestin-expressing embryonic progenitor cells and subsequently to the adult acinar compartment and Nestin-expressing cells is sufficient for the development of low grade pancreatic intraepithelial neoplasia (PanIN) between 2 and 4 months. The mice die around 6 month-old of unrelated causes, and it is therefore not possible to assess whether the lesions will progress to carcinoma. We now report that two brief episodes of caerulein-induced acute pancreatitis in 2 month-old mice causes rapid PanIN progression and pancreatic ductal adenocarcinoma (PDAC) development by 4 months of age. These events occur with similar frequency as observed in animals where the oncogene is targeted during embryogenesis ...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumour thought to arise fr...
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell model of e...
Targeting of oncogenic Kras to the pancreatic Nestin-expressing embryonic progenitor cells and subse...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
Oncogenic Kras mutations are a critical genetic event in early pancreatic carcinogenesis. However, i...
AbstractTo evaluate the role of oncogenic RAS mutations in pancreatic tumorigenesis, we directed end...
OBJECTIVE: The initial steps of pancreatic regeneration versus carcinogenesis are insufficiently und...
Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neopla...
inactivation.) were performed by IHC and/or qRT-PCR. mice represents a transient state from ADMs to...
To determine the cell compartment in which initial oncogenic mutations occur in pancreatic ductal ad...
SummaryPancreatic acinar cells of adult mice (≥P60) are resistant to transformation by some of the m...
Pancreatic ductal adenocarcinoma (PDA) is characterized by an extremely poor prognosis, since it is ...
Pancreatic cancer is the fourth leading cause of cancer related death in the United States, with pan...
Inflammation is a major risk factor for pancreatic ductal adenocarcinoma (PDAC). When occurring in t...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumour thought to arise fr...
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell model of e...
Targeting of oncogenic Kras to the pancreatic Nestin-expressing embryonic progenitor cells and subse...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
Oncogenic Kras mutations are a critical genetic event in early pancreatic carcinogenesis. However, i...
AbstractTo evaluate the role of oncogenic RAS mutations in pancreatic tumorigenesis, we directed end...
OBJECTIVE: The initial steps of pancreatic regeneration versus carcinogenesis are insufficiently und...
Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neopla...
inactivation.) were performed by IHC and/or qRT-PCR. mice represents a transient state from ADMs to...
To determine the cell compartment in which initial oncogenic mutations occur in pancreatic ductal ad...
SummaryPancreatic acinar cells of adult mice (≥P60) are resistant to transformation by some of the m...
Pancreatic ductal adenocarcinoma (PDA) is characterized by an extremely poor prognosis, since it is ...
Pancreatic cancer is the fourth leading cause of cancer related death in the United States, with pan...
Inflammation is a major risk factor for pancreatic ductal adenocarcinoma (PDAC). When occurring in t...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumour thought to arise fr...
Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis and lacks a human cell model of e...